Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin on Aortic Stiffness in Hemodialysis Patients (AURORA Substudy)
NCT00240279Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2003
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in end stage renal disease (ESRD), hypercholesterolemia, sponsored by AstraZeneca. Started Jan 2003; status: completed.
02
Drugs
rosuvastatin
03
Conditions
end stage renal disease (ESRD)hypercholesterolemia
Beyond the preview
Go deeper on NCT00240279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240279.